Psychiatry and Neurology, Neurology · Lexington, KY
NPI
1811092976
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
740 S Limestone Ste B101
Lexington, KY, 40536
Phone (859) 323-5661
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,479
59 services
Medicare patients, 2024
31
Average age 49
Drug cost, 2024
$1.3M
1,642 prescriptions
Company payments, 2025
$9,045
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Meriem K Bensalem-Owen was code 99215 (office e&m - established), 12 times for 11 patients. In total Meriem K Bensalem-Owen billed 59 services in 13 codes, and Medicare paid $5,479.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 12 | 11 | $96.88 | $1,163 |
By year: 2022 $11K for 129 services; 2023 $8,227 for 119 services; 2024 $5,479 for 59 services.
Medicare prescription drug claims, 2024
In 2024, the drug Meriem K Bensalem-Owen prescribed most often to Medicare patients was Clobazam, with 159 prescriptions and refills. In total Meriem K Bensalem-Owen wrote 1,642 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobazam Generic | 159 | 161 | 32 | $32K |
| Clonazepam Generic | 157 | 167 | 27 | $1,414 |
| Levetiracetam Generic | 152 | 196 | 35 | $7,200 |
| Lamotrigine Generic | 110 | 154 | 16 | $1,438 |
| Lacosamide Generic | 98 | 106 | 22 | $17K |
| Lamotrigine Er Lamotrigine | 69 | 73 | Under 11 | $12K |
| Briviact Brivaracetam | 67 | 69 | 11 | $95K |
| Divalproex Sodium Generic | 55 | 71 | Under 11 | $1,949 |
| Pregabalin Generic | 50 | 54 | Under 11 | $3,552 |
| Lamictal Xr Lamotrigine | 46 | 63 | Under 11 | $74K |
| Fycompa Perampanel | 45 | 45 | Under 11 | $60K |
| Topiramate Generic | 41 | 81 | 13 | $3,799 |
| Oxcarbazepine Generic | 40 | 54 | Under 11 | $2,862 |
| Nayzilam Midazolam | 30 | 30 | 11 | $42K |
| Xcopri Cenobamate | 28 | 28 | Under 11 | $39K |
Brand drugs: - claims; generic drugs: 1,180 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Meriem K Bensalem-Owen $9,045 ($413 in general payments such as food, travel and fees and $8,632 for research) from 5 companies. The largest payer was Neuropace, Inc. with $8,775.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.